Cargando…
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
BACKGROUND: Cytokines are key immune mediators in physiological and disease processes, whose increased levels have been associated with the physiopathology of hematopoietic malignancies, such as myeloproliferative neoplasms. METHODS: This study examined the plasma cytokine profiles of patients with...
Autores principales: | Cacemiro, Maira da Costa, Cominal, Juçara Gastaldi, Tognon, Raquel, Nunes, Natalia de Souza, Simões, Belinda Pinto, Figueiredo-Pontes, Lorena Lôbo de, Catto, Luiz Fernando Bazzo, Traina, Fabíola, Souto, Elizabeth Xisto, Zambuzi, Fabiana Albani, Frantz, Fabiani Gai, Castro, Fabíola Attié de |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001283/ https://www.ncbi.nlm.nih.gov/pubmed/30057985 http://dx.doi.org/10.1016/j.htct.2017.12.003 |
Ejemplares similares
-
Erratum on “Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation”
por: Cacemiro, Maira da Costa, et al.
Publicado: (2021) -
Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
por: Cominal, Juçara Gastaldi, et al.
Publicado: (2021) -
Differential cytokine network profile in polycythemia vera and secondary polycythemia
por: Cacemiro, Maira da Costa, et al.
Publicado: (2020) -
Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies
por: Cominal, Juçara Gastaldi, et al.
Publicado: (2019) -
Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype
por: Bassan, Vitor Leonardo, et al.
Publicado: (2022)